Cosibelimab for CSCC in Patients With Kidney Transplant or Hematologic Malignancy
Dana-Farber Cancer Institute
Dana-Farber Cancer Institute
Dana-Farber Cancer Institute
M.D. Anderson Cancer Center
Dana-Farber Cancer Institute
OHSU Knight Cancer Institute
Emory University
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Dana-Farber Cancer Institute
AIO-Studien-gGmbH
Mayo Clinic
Mayo Clinic
Mayo Clinic
University of Cologne
Mayo Clinic
Mayo Clinic
M.D. Anderson Cancer Center
University of California, Davis
Dana-Farber Cancer Institute
Alliance for Clinical Trials in Oncology
Boston Medical Center
Duke University
Swiss Cancer Institute
Samsung Medical Center
M.D. Anderson Cancer Center
Massachusetts General Hospital
International Extranodal Lymphoma Study Group (IELSG)
City of Hope Medical Center
Technical University of Munich